Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2016-01-01
2017-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
NCT01258842
Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity
NCT01896154
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05284851
Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
NCT01674205
Influenza Immunity in Children
NCT02559505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Seasonal Influenza Vaccine (H1N1, H3N2, PhuB) and 100 ml bottle of yoghurt drink, unlabelled drinking fermented milk containing probiotic, Lactobacillus paracasei (IMULUS)
Drinking fermented milk
Drinking fermented milk containing Lactobacillus paracasei (IMULUS)
Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)
Intramuscular injection of a single shot of influenza vaccine
control group
Seasonal Influenza Vaccine (H1N1, H3N2, PhuB) and 100 ml bottle of placebo, unlabelled acidified milk with similar physical and sensory appearance to the experimental one
placebo
Acidified placebo milk with similar physical characteristics to the yoghurt drink
Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)
Intramuscular injection of a single shot of influenza vaccine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drinking fermented milk
Drinking fermented milk containing Lactobacillus paracasei (IMULUS)
placebo
Acidified placebo milk with similar physical characteristics to the yoghurt drink
Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)
Intramuscular injection of a single shot of influenza vaccine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy and having normal vital signs
* no history of uncontrolled systemic or autoimmune diseases
* no signs or symptoms of respiratory infection
* normal blood chemistry including complete blood count (CBC), liver and kidney function, lipid profile and fasting blood sugar
* no history of influenza vaccine during the past 6 months
* able to continuously take the intervention daily for 6 weeks
* able to refrain from other probiotic products such as drinking fermented milk or yoghurt since the beginning till the end of data collection
* accepted to receive influenza vaccine shot
* able to refrain from receiving other vaccine during the trial
* able to refrain from traveling to endemic area of influenza
* able to communicate in Thai and sign their written inform consent
Exclusion Criteria
* lactose or milk protein intolerances
* daily intake of probiotic product for one month prior to recruitment
* chronic alcoholism
* GI disturbance e.g. stomachache, frequent diarrhea or constipation
* history of GI surgery
* ongoing treatment with antibiotic or other immune affecting drugs e.g. glucocorticoids, chemotherapy, antibodies, ciclosporin, hormone and opioids
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dunyaporn Trachootham
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dunyaporn Trachootham, DDS, PhD
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MU-CIRB 2015/145.2509
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.